Filter Results

Locations

Study status

(for at least one location)

Gender

Age

Healthy Volunteer

What is this?
A volunteer subject with no known significant health problems who participates in research to test a new drug, device or intervention. These volunteers are recruited to serve as controls for patient groups. Healthy volunteers receive the same test, procedure, or drug the patient group receives.

Study phase

What is this?
During the early phases (phases 1 and 2), researchers assess safety, side effects, optimal dosages and risks/benefits. In the later phase (phase 3), researchers study whether the treatment works better than the current standard therapy. They also compare the safety of the new treatment with that of current treatments. Phase 3 trials include large numbers of people to make sure that the result is valid. There are also less common very early (phase 0) and later (phase 4) phases. Phase 0 trials are small trials that help researchers decide if a new agent should be tested in a phase 1 trial. Phase 4 trials look at long-term safety and effectiveness, after a new treatment has been approved and is on the market.

Search Results 31-40 of 41 for Neuroendocrine tumor

Edit search filters
  1. Prognostic and Predictive Biomarkers in Neuroendocrine Tumors

    Rochester, MN

  2. Neuroendocrine Tumors - Patient Reported Outcomes

    Rochester, MN

  3. A Registry of Biospecimens at Mayo Clinic to Support Translational Research into the Biology, Etiology and Prognosis of Neuroendocrine Tumors

    Jacksonville, FL

  4. Care Processes and Person Centered Care of Patients with Neuroendocrine Tumors

    Rochester, MN

  5. Study Using Chromogranin A as Surveillance Biomarker in Patients with cARcinoids

    Rochester, MN

  6. A Study to Evaluate CHIP and Hematological Toxicity After PRRT in Neuroendocrine Tumor Patients

    Scottsdale/Phoenix, AZ, Rochester, MN, Jacksonville, FL

  7. A Study Using Octreotide Scan versus PET Scan in the Diagnosis and Follow-up of Patients with Carcinoid and Neuroendocrine Tumors

    Scottsdale/Phoenix, AZ

  8. Correlation of Pancreatic Islet Morphology with Postprandial Glucose Tolerance in Subjects Undergoing Pancreatic Resection for Islet Cell Tumors

    Rochester, MN

  9. A Survey of Pheochromocytoma and Paraganglioma Patient Environment

    Rochester, MN

  10. Evaluation of Neuroendocrine Differentiation as a Potential Mechanism of Tumor Recurrence Following Radiotherapy in Prostate Carcinoma

    Jacksonville, FL, Rochester, MN, Scottsdale/Phoenix, AZ

.

Mayo Clinic Footer